BioMarin Pharmaceutical(BMRN) - 2025 Q3 - Earnings Call Transcript

BioMarin Pharmaceutical (NasdaqGS:BMRN) Q3 2025 Earnings Call October 27, 2025 04:30 PM ET Company ParticipantsZaki Molvi - Senior Associate of Biotechnology Equity ResearchJulian Pino - Senior Associate of Biotechnology Equity ResearchTraci McCarty - Head of Investor RelationsAlexander Hardy - President and CEOCristin Hubbard - Chief Commercial OfficerChris Raymond - Managing DirectorBrian Mueller - CFOGreg Friberg - Chief Research and Development OfficerConference Call ParticipantsSalveen Richter - Biotec ...